Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 9:41 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.1% | 0 (Unchanged) | View |
| 2024-02-12 9:12 pm Purchase | 13D | RALLYBIO CORP COM RLYB | Pivotal bioVenture Partners Fund I L.P. | 2,404,644 6.4% | 133,333 (+5.87%) | View |
| 2024-02-12 9:06 pm Sale | 13G | OCULIS HLDG AG NAMEN AKT OCS | Pivotal bioVenture Partners Fund I L.P. | 2,414,972 7.4% | -617,324 (-20.36%) | View |
| 2024-02-12 9:06 pm Unchanged | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 4,494,851 7.2% | 0 (Unchanged) | View |
| 2023-08-07 9:58 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 4,494,851 9.5% | 833,333 (+22.76%) | View |
| 2023-05-23 4:48 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 3,661,518 8.3% | 447,932 (+13.94%) | View |
| 2023-04-04 08:59 am Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 3,213,586 7.4% | 552,432 (+20.76%) | View |
| 2023-03-15 12:53 pm Purchase | 13G | OCULIS HLDG AG NAMEN AKT OCS | Pivotal bioVenture Partners Fund I L.P. | 3,032,296 9.3% | 3,032,296 (New Position) | View |
| 2022-08-25 4:07 pm Unchanged | 13G | AKOUOS INC AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 4.9% | 0 (Unchanged) | View |
| 2022-04-28 4:58 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 2,661,154 6.6% | 1,070,000 (+67.25%) | View |
| 2022-02-14 09:26 am Unchanged | 13G | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.7% | 0 (Unchanged) | View |
| 2022-02-14 09:18 am Unchanged | 13G | AKOUOS INC AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.2% | 0 (Unchanged) | View |
| 2021-08-13 5:02 pm Purchase | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.4% | 1,166,952 (+61.70%) | View |
| 2021-08-12 5:00 pm Purchase | 13D | RALLYBIO CORP COM RLYB | Pivotal bioVenture Partners Fund I L.P. | 2,271,311 7.3% | 2,271,311 (New Position) | View |
| 2021-02-17 4:56 pm Purchase | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 1,891,467 5.5% | 1,891,467 (New Position) | View |
| 2021-02-09 5:08 pm Unchanged | 13G | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.8% | 0 (Unchanged) | View |
| 2021-02-09 5:02 pm Unchanged | 13G | AKOUOS INC AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.2% | 0 (Unchanged) | View |
| 2021-02-09 5:02 pm Sale | 13G | ITERUM THERAPEUTICS LTD ITRM | Pivotal bioVenture Partners Fund I L.P. | 945,085 1.2% | -1 (-0.00%) | View |
| 2020-08-04 08:30 am Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 1,591,154 7.1% | 1,591,154 (New Position) | View |
| 2020-07-10 09:26 am Purchase | 13D | AKOUOS INC AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.5% | 1,794,088 (New Position) | View |